Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese

The American Journal of Cardiology
Tomohiro SakamotoMulticenter Study for Aggressive Lipid-Lowering Strategy by HMG-CoA Reductase Inhibitors in Patients With Acute Myocardial I

Abstract

Statins have been shown to prevent coronary artery disease and to preserve left ventricular function in dilated cardiomyopathy. We hypothesized that early use of statins would decrease cardiovascular events, including heart failure in patients with acute myocardial infarction (AMI). To examine the effect of statins in Japanese patients with AMI, a prospective, randomized, open-label trial was conducted in 486 patients with normal total cholesterol levels. Patients were randomly assigned to receive any available statin (n = 241) within 96 hours of AMI onset or no statin (n = 245) and were followed for up to 24 months. The primary end point was a composite of cardiovascular death, nonfatal AMI, recurrent symptomatic myocardial ischemia, congestive heart failure, and stroke. Event rate for the primary end point was lower in the statin group than in the nonstatin group (6.1% vs 11.4%, p = 0.0433). The statin group had a lower risk of congestive heart failure and symptomatic myocardial ischemia (p = 0.0154 and 0.0264, respectively). In conclusion, early lipid-lowering therapy with statins decreases recurrent cardiovascular events, in particular, congestive heart failure.

References

Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Dec 11, 2002·European Heart Journal·A H LiemUNKNOWN FLuvastatin On Risk Diminishment after Acute myocardial infarction study group
Apr 15, 2004·The American Journal of Cardiology·UNKNOWN Japanese beta-Blockers and Calcium Antagonists Myocardial Infarction (JBCMI) Investigators

❮ Previous
Next ❯

Citations

May 29, 2007·Heart Failure Reviews·Antonio Rodríguez-SinovasDavid Garcia-Dorado
Aug 19, 2007·Heart Failure Reviews·Sofia G TsouliMoses S Elisaf
Dec 2, 2009·Current Heart Failure Reports·Helene Glassberg
Aug 6, 2011·Journal of Cardiovascular Translational Research·Kathy Yuan Ye, Lauren Deems Black
Mar 24, 2007·Nature Clinical Practice. Cardiovascular Medicine·Michael J LipinskiGeorge W Vetrovec
Aug 20, 2011·International Journal of Clinical Practice·N Verma, V M Figueredo
Dec 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Hiroshi SatoUNKNOWN Osaka Acute Coronary Insufficiency Study (OACIS)-LIPID Study Investigators
Oct 25, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Yutaka FurukawaUNKNOWN CREDO-Kyoto Investigators
Feb 18, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Sunao KojimaUNKNOWN Multicenter Study for Aggressive Lipid-lowering Strategy by HMG-CoA Reductase Inhibitors Investigators
Mar 18, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Takahide KohroUNKNOWN JCAD Investigators
Jul 31, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Tomohiro Sakamoto, Hisao Ogawa
Aug 13, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Yasuhiko Sakata
Feb 28, 2009·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Hisao OgawaTomohiro Sakamoto
Jul 31, 2013·Journal of Atherosclerosis and Thrombosis·Tamio TeramotoKoutaro Yokote
Feb 16, 2010·Journal of Atherosclerosis and Thrombosis·Kouichiro AiharaHiroyuki Daida
Jun 27, 2009·Journal of Atherosclerosis and Thrombosis·Tomoaki SaekiGenjiro Kimura
Feb 23, 2013·Heart and Vessels·Hidehiro KanekoTakeshi Yamashita
Jan 8, 2011·Expert Opinion on Investigational Drugs·Agata Bielecka-DabrowaMaciej Banach
Feb 4, 2016·Current Neurology and Neuroscience Reports·Sudeepta Dandapat, Jennifer G Robinson
Nov 14, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Atsushi IzawaUichi Ikeda
Nov 24, 2011·Heart Failure Clinics·Arvind Bhimaraj, W H Wilson Tang
Nov 10, 2009·International Journal of Cardiology·Shinobu KojimaHisao Ogawa
Nov 13, 2015·Journal of Atherosclerosis and Thrombosis·Ryo NaitoHiroyuki Daida
Jun 27, 2008·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Zeljko Reiner
Apr 25, 2008·Heart Failure Clinics·Amit Kumar, Christopher P Cannon
Jan 12, 2008·The American Journal of Medicine·Christopher O'ReganEdward J Mills
Mar 16, 2012·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Simone PostPieter A Doevendans
May 29, 2007·The American Journal of Cardiology·Michitaka NagashimaUNKNOWN Heart Institute of Japan, Department of Cardiology (HIJC) Investigators
Nov 8, 2007·Journal of Atherosclerosis and Thrombosis·Tamio TeramotoUNKNOWN Committee for Epidemiology and Clinical Management of Atherosclerosis
Sep 9, 2008·Journal of Atherosclerosis and Thrombosis·Tamio TeramotoMasayuki Yokode
Oct 3, 2009·Journal of the American College of Cardiology·Ryan P MorrisseySanjay Kaul

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

© 2022 Meta ULC. All rights reserved